Fabian Maass

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Cerebrospinal Fluid

Advance Care Planning

Protein Protein

Tandem Mass Spectrometry

Top Venues

Journal of neurochemistry

Movement disorders : official journal of the Movement Disorder Society

Clinical and translational medicine

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Asuncion Carmona, Eleonora Carboni, Lucas Caldi Gomes, Stéphane Roudeau, Fabian Maass, Christof Lenz, Richard Ortega, Paul Lingor
Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease or multiple sclerosis. Journal of neurochemistry (2024)
Asuncion Carmona, Eleonora Carboni, Lucas Caldi Gomes, Stéphane Roudeau, Fabian Maass, Christof Lenz, Richard Ortega, Paul Lingor
Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease or multiple sclerosis. Journal of neurochemistry 168 (2) (2024)
Asuncion Carmona, Eleonora Carboni, Lucas Caldi Gomes, Stéphane Roudeau, Fabian Maass, Christof Lenz, Richard Ortega, Paul Lingor
Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease or multiple sclerosis. Journal of neurochemistry 168 (2) (2024)
Asuncion Carmona, Eleonora Carboni, Lucas Caldi Gomes, Stéphane Roudeau, Fabian Maass, Christof Lenz, Richard Ortega, Paul Lingor
Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease or multiple sclerosis. Journal of neurochemistry 168 (2) (2024)
Fabian Maass, Ala Jamous, Saskia Biskup, Hanna Eisenberg, Zara D'Hedouville, Mathias Bähr, Christoph van Riesen
Spinocerebellar Ataxia Type 35 Caused by a New TGM6 Variant: Video Documentation of a German Family. Movement disorders clinical practice 10 (6) (2023)
Lucas Caldi Gomes, Ana Galhoz, Gaurav Jain, Anna-Elisa Roser, Fabian Maass, Eleonora Carboni, Elisabeth Barski, Christof Lenz, Katja Lohmann, Christine Klein, Mathias Bähr, Andre Fischer, Michael Patrick Menden, Paul Lingor
Multi-omic landscaping of human midbrains identifies disease-relevant molecular targets and pathways in advanced-stage Parkinson's disease. Clinical and translational medicine 12 (1) (2022)
Lucas Caldi Gomes, Anna-Elisa Roser, Gaurav Jain, Tonatiuh Pena Centeno, Fabian Maass, Lukas Schilde, Caroline May, Anja Schneider, Mathias Bähr, Katrin Marcus, Andre Fischer, Paul Lingor
MicroRNAs from extracellular vesicles as a signature for Parkinson's disease. Clinical and translational medicine 11 (4) (2022)
Fabian Maass, Bernhard Michalke, Desiree Willkommen, Sezgi Canaslan, Matthias Schmitz, Mathias Bähr, Inga Zerr, Paul Lingor
Cerebrospinal Fluid Iron-Ferritin Ratio as a Potential Progression Marker for Parkinson's Disease. Movement disorders : official journal of the Movement Disorder Society (2021)
Matthias Schmitz, Sezgi Canaslan, Anna Villar-Piqué, Karin Gmitterová, Daniela Varges, Paul Lingor, Franc Llorens, Peter Hermann, Fabian Maass, Inga Zerr
Validation of Plasma Neurofilament Light Chain as a Marker for α-Synucleinopathies. Movement disorders : official journal of the Movement Disorder Society 36 (11) (2021)
Fabian Maass, Sebastian Rikker, Vivian Dambeck, Carmina Warth, Lars Tatenhorst, Ilona Csoti, Matthias Schmitz, Inga Zerr, Andreas Leha, Mathias Bähr, Paul Lingor
Increased alpha-synuclein tear fluid levels in patients with Parkinson's disease. Scientific reports 10 (1) (2020)
Fabian Maass, Bernhard Michalke, Andreas Leha, Matthias Boerger, Inga Zerr, Jan-Christoph Koch, Lars Tönges, Mathias Bähr, Paul Lingor
Elemental fingerprint as a cerebrospinal fluid biomarker for the diagnosis of Parkinson's disease. Journal of neurochemistry 145 (4) (2018)